Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
AU560262B2 - Antibodies derived from hybrid line from (myeloma + antibody producing cell) - Google Patents
[go: Go Back, main page]

AU560262B2 - Antibodies derived from hybrid line from (myeloma + antibody producing cell) - Google Patents

Antibodies derived from hybrid line from (myeloma + antibody producing cell)

Info

Publication number
AU560262B2
AU560262B2 AU89454/82A AU8945482A AU560262B2 AU 560262 B2 AU560262 B2 AU 560262B2 AU 89454/82 A AU89454/82 A AU 89454/82A AU 8945482 A AU8945482 A AU 8945482A AU 560262 B2 AU560262 B2 AU 560262B2
Authority
AU
Australia
Prior art keywords
myeloma
producing cell
antibody producing
antibodies derived
hybrid line
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU89454/82A
Other versions
AU8945482A (en
Inventor
Peter L. Sadowski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MGI Pharma Inc
Original Assignee
Molecular Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molecular Genetics Inc filed Critical Molecular Genetics Inc
Publication of AU8945482A publication Critical patent/AU8945482A/en
Application granted granted Critical
Publication of AU560262B2 publication Critical patent/AU560262B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU89454/82A 1981-10-19 1982-10-18 Antibodies derived from hybrid line from (myeloma + antibody producing cell) Ceased AU560262B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31299381A 1981-10-19 1981-10-19
US312993 1981-10-19

Publications (2)

Publication Number Publication Date
AU8945482A AU8945482A (en) 1983-04-28
AU560262B2 true AU560262B2 (en) 1987-04-02

Family

ID=23213904

Family Applications (1)

Application Number Title Priority Date Filing Date
AU89454/82A Ceased AU560262B2 (en) 1981-10-19 1982-10-18 Antibodies derived from hybrid line from (myeloma + antibody producing cell)

Country Status (4)

Country Link
JP (1) JPS5899423A (en)
AU (1) AU560262B2 (en)
DK (1) DK462182A (en)
NZ (1) NZ202203A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU585200B2 (en) * 1983-05-06 1989-06-15 Velos Group Monoclonal antibodies reactive with endotoxin core

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60123428A (en) * 1983-12-05 1985-07-02 Green Cross Corp:The Remedy for diarrhea
DK219084D0 (en) * 1984-05-02 1984-05-02 Frederik Carl Peter Lindberg ANTIGEN
JP7570216B2 (en) * 2020-11-30 2024-10-21 株式会社ヤクルト本社 Screening method for microorganisms that colonize the human intestine for a long period of time

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU585200B2 (en) * 1983-05-06 1989-06-15 Velos Group Monoclonal antibodies reactive with endotoxin core

Also Published As

Publication number Publication date
JPS5899423A (en) 1983-06-13
AU8945482A (en) 1983-04-28
DK462182A (en) 1983-04-20
NZ202203A (en) 1986-05-09

Similar Documents

Publication Publication Date Title
AU564383B2 (en) Monoclonal antibody immunoassay
AU4649585A (en) Immunoassay for breast cancer employing monoclonal antibodies
DE3372785D1 (en) Monoclonal antibodies against lens epithelial cells
AU3708878A (en) Hybridoma antibodies
EP0095346A3 (en) Hybrid cell lines producing monoclonal antibodies directed against treponema
AU537806B2 (en) Monoclonal antibody
GB8316001D0 (en) Monoclonal antibodies
GB8426463D0 (en) Monoclonal antibodies
GB8422653D0 (en) Monoclonal antibodies
GB8422650D0 (en) Monoclonal antibodies
AU567681B2 (en) Immunoassay involving monoclonal igm antibody
AU7784187A (en) Monoclonal antibody against ovarian cancer cells (ovb-3)
AU1286983A (en) Cell hybrid which secretes monoclonal antibodies
AU560262B2 (en) Antibodies derived from hybrid line from (myeloma + antibody producing cell)
AU9019382A (en) Acetylcholine receptors or antibodies or anti-antibodies bound to carrier
AU8077282A (en) Antibodies to proteins
EP0141616A3 (en) Hybrid cell lines producing monoclonal antibodies directed against trichomonas vaginalis determinants
GB8426461D0 (en) Monoclonal antibodies
GB8426464D0 (en) Monoclonal antibodies
GB8422649D0 (en) Monoclonal antibodies
GB8426468D0 (en) Monoclonal antibodies
AU618720B2 (en) Monoclonal antibodies
FI820200A7 (en) Method for preparing antibody-producing hybrid cells and antibodies, hybrid cells and antibodies.
AU2900184A (en) Membrane antigens generated from pooled cells and monoclonal antibodies
GB8426459D0 (en) Monoclonal antibodies